| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,454 |
13,257 |
$1.22M |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
2,041 |
2,040 |
$369K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
69 |
66 |
$73K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
897 |
889 |
$61K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
41 |
38 |
$49K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
383 |
354 |
$47K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
13 |
12 |
$18K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
387 |
382 |
$16K |
| 96415 |
|
347 |
323 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
90 |
90 |
$2K |
| 20610 |
|
34 |
26 |
$1K |
| 76942 |
|
29 |
25 |
$756.08 |